ophthalmologic exams
Otherophthalmologic exams such as vision, intraocular pressure, axial length and optical coherence tomography
NCT Number: NCT03434145
To evaluate the effect of hemodialysis on various ophthalmologic parameters in patients with end-stage kidney disease (ESRD).
Looking for future studies?
Notify Me20 year–80 year
All sexes
Observational
Subjects: patients with ESRD undergoing hemodialysis at the Dialysis Center of Hanyang Guri Hospital
Ocular parameters: visual acuity, intraocular pressure, axial length, OCT Other systemic parameters: body weight, ultrafiltration volume, and systolic/diastolic blood pressure
All measurements were performed near the dialysis center. Measurements were performed on Monday (for patients who underwent dialysis sessions on Monday, Wednesday, and Friday) or Tuesday (for patients who underwent dialysis sessions on Tuesday, Thursday, and Saturday.
All parameters were measured before and after the hemodialysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ophthalmologic exams such as vision, intraocular pressure, axial length and optical coherence tomography
Time frame: immediately (within 10 minutes) before and after hemodialysis
retinal & choroidal thickness on OCT
Time frame: immediately (within 10 minutes) before and after hemodialysis
vessel density on OCTA
Time frame: immediately (within 10 minutes) before and after hemodialysis
intraocular pressure, retinal thickness, anterior chamber angle
Hanyang University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05354726
Chronic Disease, Chronic Kidney Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06203977
Chronic Disease, Chronic Kidney Diseases
Edmonton, Alberta, Canada
View Trial DetailsNCT06362759
C-reactive Protein, Chronic Disease
Birmingham, Alabama, United States
View Trial DetailsNCT03386539
Behavior, Cardiac Allograft Vasculopathy
Birmingham, Alabama, United States
View Trial Details